Striatal Tonically Active Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Striatal Tonically Active Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Striatal tonically active interneurons (TANs), also known as cholinergic interneurons or aspiny neurons, represent a unique and critical population within the striatum. Unlike most striatal neurons, these cells maintain autonomous firing patterns and provide extensive cholinergic modulation throughout the basal ganglia. TANs are essential for reward learning, motor control, and are prominently affected in Parkinson's disease. [@pisani2015]
Molecular Markers
Striatal tonically active interneurons are characterized by: [@ding2016]
CHAT: Choline acetyltransferase, the enzyme synthesizing acetylcholine
VACHT: Vesicular acetylcholine transporter for ACh packaging
p75NTR: Low-affinity nerve growth factor receptor
TrkA: Tropomyosin receptor kinase A, high-affinity NGF receptor
Muscarinic receptors: M1-M5 subtypes (autoreceptors and heteroreceptors)
Nicotinic receptors: Various subunits for cholinergic signaling
Tyrosine hydroxylase: Present in some subpopulations
Morphology
TANs exhibit distinctive morphological features: [@ref]
Cell body size: Large somata (20-30 μm diameter), largest in striatum
Dendritic architecture: Extensive dendritic fields covering large striatal volumes
Membrane properties: Low input resistance, long membrane time constants
Autonomous activity: Fire spontaneously without synaptic input
Pause responses: Paused firing in response to salient stimuli
Neuromodulation: Strongly modulated by dopamine, reward signals
Acetylcholine release: Maintain ambient extracellular ACh levels
Role in Neurodegeneration
Parkinson's Disease
TANs are prominently affected in Parkinson's disease and contribute to motor deficits: [@refb]
Altered firing patterns: In PD patients and animal models, TANs show irregular firing and altered pause responses [1](https://pubmed.ncbi.nlm.nih.gov/25481454/).
Dopamine-acetylcholine imbalance: Loss of dopaminergic signaling disrupts the delicate dopamine-ACh balance in the striatum, contributing to motor dysfunction [2](https://pubmed.ncbi.nlm.nih.gov/26227653/).
Cortical dysfunction: TANs integrate cortical and thalamic inputs; their dysfunction contributes to impaired motor planning [3](https://pubmed.ncbi.nlm.nih.gov/25694221/).
Anticholinergic therapies: Historical PD treatments target muscarinic receptors to compensate for TAN dysfunction [4](https://pubmed.ncbi.nlm.nih.gov/25855793/).
Deep brain stimulation effects: STN-DBS modulates TAN activity, contributing to therapeutic effects [5](https://pubmed.ncbi.nlm.nih.gov/26584575/).
Alzheimer's Disease
TANs and the striatal cholinergic system contribute to cognitive decline: [@refc]
Basal forebrain interactions: The basal forebrain cholinergic system interacts with striatal TANs; both are affected in AD [6](https://pubmed.ncbi.nlm.nih.gov/24726726/).
Memory dysfunction: Striatal cholinergic signaling contributes to habit learning, disrupted in AD [7](https://pubmed.ncbi.nlm.nih.gov/25393508/).
Acetylcholine replacement: Cholinergic therapies may benefit striatal circuits [8](https://pubmed.ncbi.nlm.nih.gov/25915662/).
Huntington's Disease
Early changes: TANs show early functional alterations before overt degeneration [9](https://pubmed.ncbi.nlm.nih.gov/26656257/).
Motor dysfunction: Cholinergic dysregulation contributes to chorea and motor impairments [10](https://pubmed.ncbi.nlm.nih.gov/27138721/).
Dystonia
Cholinergic hyperactivity: Excessive TAN activity contributes to abnormal movements in dystonia [11](https://pubmed.ncbi.nlm.nih.gov/26801234/).
Therapeutic Implications
TANs represent therapeutic targets for multiple conditions: [@refd]
Anticholinergic drugs: Trihexyphenidyl, benztropine for PD motor symptoms
Muscarinic modulators: M4 muscarinic receptor ligands show promise [12](https://pubmed.ncbi.nlm.nih.gov/27272723/).
Nicotinic agonists: α4β2 nicotinic receptor activation may improve function [13](https://pubmed.ncbi.nlm.nih.gov/26134469/).
DBS modulation: Understanding TAN responses to DBS may improve targeting [14](https://pubmed.ncbi.nlm.nih.gov/26291412/).
Circuit Functions
Striatal tonically active interneurons serve multiple critical functions: [@refe]
Reward Learning
Reward prediction errors: TANs signal reward prediction errors through pause responses
Striatal Tonically Active Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [@refg]
Background
The study of Striatal Tonically Active Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@refh]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@refi]
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data